Stock listing
OTC:CRNOF Cereno Scientific AB Stock
US listing (OTC) of Cereno Scientific AB · home listing Stockholm:CRNOB
Follow Cereno Scientific AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:CRNO_B
1.91 SEK -0.09 (-4.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:CRNO_B
- Day range
- 1.90 – 2.50 SEKNov 2, 2026
- Volume
- 6.95M sharesNov 2, 2026
- Market cap
- 616.2M SEKAt the close on Nov 2, 2026 · price × 323.1M shares outstanding
- 52-week range
- 1.90 – 8.92 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- 3.17M SEKMedian day 551,756 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Frankfurt:4A1 | €0.167 EUR | -0.136 (-44.8%) | — | €0.213 | €0.213 | €0.167 | €0.303 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:CRNO_B · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 1.907 | -0.093 | -4.6% | 2.20 | 2.50 | 1.902 | 6,945,090 | |
| 2.00 | -0.512 | -20.4% | 2.522 | 2.588 | 1.951 | 6,167,177 | |
| 2.512 | -0.472 | -15.8% | 2.978 | 2.978 | 2.48 | 4,505,602 | |
| 2.984 | -0.012 | -0.4% | 3.03 | 3.074 | 2.92 | 671,490 | |
| 2.996 | -0.078 | -2.5% | 3.074 | 3.098 | 2.978 | 589,328 | |
| 3.074 | +0.116 | +3.9% | 2.99 | 3.128 | 2.898 | 1,171,987 | |
| 2.958 | -0.21 | -6.6% | 3.452 | 3.452 | 2.802 | 1,997,805 | |
| 3.168 | +0.028 | +0.9% | 3.14 | 3.318 | 3.102 | 549,265 | |
| 3.14 | -0.202 | -6.0% | 3.348 | 3.394 | 2.998 | 2,119,396 | |
| 3.342 | -0.114 | -3.3% | 3.456 | 3.548 | 3.296 | 991,597 | |
| 3.456 | -0.076 | -2.2% | 3.522 | 3.718 | 3.412 | 246,359 | |
| 3.532 | -0.04 | -1.1% | 3.458 | 3.56 | 3.422 | 473,520 | |
| 3.572 | +0.124 | +3.6% | 3.432 | 3.60 | 3.236 | 1,191,536 | |
| 3.448 | -0.042 | -1.2% | 3.496 | 3.618 | 3.418 | 510,931 | |
| 3.49 | -0.16 | -4.4% | 3.65 | 3.688 | 3.472 | 554,246 | |
| 3.65 | -0.17 | -4.5% | 3.78 | 3.78 | 3.578 | 752,181 | |
| 3.82 | +0.27 | +7.6% | 3.546 | 3.974 | 3.43 | 1,181,626 | |
| 3.55 | -0.038 | -1.1% | 3.552 | 3.738 | 3.35 | 1,803,978 | |
| 3.588 | -0.162 | -4.3% | 3.734 | 3.734 | 3.52 | 1,906,099 | |
| 3.75 | -0.21 | -5.3% | 3.978 | 3.978 | 3.71 | 1,529,637 | |
| 3.96 | -0.086 | -2.1% | 4.026 | 4.028 | 3.948 | 381,899 | |
| 4.046 | -0.032 | -0.8% | 4.06 | 4.10 | 3.988 | 329,388 | |
| 4.078 | -0.108 | -2.6% | 4.15 | 4.15 | 3.94 | 558,571 | |
| 4.186 | +0.058 | +1.4% | 4.128 | 4.198 | 4.026 | 313,835 | |
| 4.128 | +0.134 | +3.4% | 3.99 | 4.148 | 3.824 | 970,555 | |
| 3.994 | -0.128 | -3.1% | 4.184 | 4.20 | 3.902 | 1,708,657 | |
| 4.122 | +0.038 | +0.9% | 4.12 | 4.656 | 4.07 | 1,687,832 | |
| 4.084 | -0.152 | -3.6% | 4.158 | 4.20 | 4.008 | 564,608 | |
| 4.236 | +0.01 | +0.2% | 4.228 | 4.254 | 4.124 | 407,663 | |
| 4.226 | -0.094 | -2.2% | 4.292 | 4.426 | 4.206 | 509,544 | |
| 4.32 | -0.14 | -3.1% | 4.512 | 4.512 | 4.30 | 912,929 | |
| 4.46 | -0.16 | -3.5% | 4.60 | 4.618 | 4.46 | 255,470 | |
| 4.62 | -0.042 | -0.9% | 4.652 | 4.718 | 4.53 | 555,834 | |
| 4.662 | +0.044 | +1.0% | 4.586 | 4.666 | 4.542 | 208,750 | |
| 4.618 | +0.074 | +1.6% | 4.50 | 4.74 | 4.418 | 376,200 | |
| 4.544 | -0.08 | -1.7% | 4.62 | 4.62 | 4.45 | 340,618 | |
| 4.624 | -0.024 | -0.5% | 4.506 | 4.688 | 4.506 | 285,793 | |
| 4.648 | +0.078 | +1.7% | 4.578 | 4.698 | 4.524 | 581,873 | |
| 4.57 | +0.234 | +5.4% | 4.336 | 4.578 | 4.25 | 761,486 | |
| 4.336 | -0.018 | -0.4% | 4.30 | 4.354 | 4.21 | 285,830 | |
| 4.354 | -0.008 | -0.2% | 4.308 | 4.374 | 4.212 | 499,959 | |
| 4.362 | +0.124 | +2.9% | 4.156 | 4.45 | 4.112 | 1,295,919 | |
| 4.238 | -0.122 | -2.8% | 4.302 | 4.378 | 4.15 | 914,525 | |
| 4.36 | -0.01 | -0.2% | 4.318 | 4.598 | 4.246 | 347,179 | |
| 4.37 | +0.012 | +0.3% | 4.356 | 4.43 | 4.25 | 293,839 | |
| 4.358 | -0.084 | -1.9% | 4.442 | 4.45 | 4.30 | 722,243 | |
| 4.442 | -0.112 | -2.5% | 4.558 | 4.592 | 4.426 | 756,778 | |
| 4.554 | +0.03 | +0.7% | 4.50 | 4.794 | 4.45 | 694,469 | |
| 4.524 | -0.182 | -3.9% | 4.708 | 4.708 | 4.472 | 1,146,059 | |
| 4.706 | +0.106 | +2.3% | 4.602 | 4.72 | 4.602 | 308,887 | |
| 4.60 | -0.05 | -1.1% | 4.652 | 4.722 | 4.556 | 313,456 | |
| 4.65 | -0.006 | -0.1% | 4.598 | 4.748 | 4.512 | 456,030 | |
| 4.656 | -0.04 | -0.9% | 4.654 | 4.656 | 4.518 | 446,289 | |
| 4.696 | -0.114 | -2.4% | 4.748 | 4.748 | 4.62 | 280,264 | |
| 4.81 | +0.002 | 0.0% | 4.774 | 4.81 | 4.70 | 158,343 | |
| 4.808 | -0.078 | -1.6% | 4.886 | 4.886 | 4.74 | 333,459 | |
| 4.886 | -0.074 | -1.5% | 5.00 | 5.00 | 4.77 | 358,971 | |
| 4.96 | +0.15 | +3.1% | 4.762 | 5.13 | 4.692 | 655,136 | |
| 4.81 | +0.07 | +1.5% | 4.848 | 4.85 | 4.68 | 374,569 | |
| 4.74 | -0.144 | -2.9% | 4.886 | 4.896 | 4.74 | 389,633 | |
| 4.884 | +0.036 | +0.7% | 4.85 | 4.978 | 4.814 | 320,395 | |
| 4.848 | +0.05 | +1.0% | 4.784 | 4.896 | 4.736 | 645,725 | |
| 4.798 | +0.034 | +0.7% | 4.766 | 4.838 | 4.67 | 360,611 | |
| 4.764 | -0.016 | -0.3% | 4.928 | 4.928 | 4.682 | 239,839 | |
| 4.78 | -0.044 | -0.9% | 4.77 | 4.948 | 4.738 | 357,712 | |
| 4.824 | -0.002 | 0.0% | 4.74 | 4.848 | 4.70 | 269,514 |
- Ticker
- OTC:CRNOF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Mar 31, 2026
Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
Latest deck · Apr 24, 2026
Nordic Health Summit Japan 2026
Conference · 9 slides
Latest news
Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
Mar 31, 2026
Closed 6.24 (-16.0%) on Mar 31, 2026
Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
Mar 17, 2026
Closed 6.49 (+11.5%) on Mar 17, 2026
Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
Feb 4, 2026
Closed 6.53 (0.0%) on Feb 4, 2026
Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014: Antithrombotic Efficacy Without Bleeding Risk Supports Broad Potential in Cardiopulmonary Diseases
Jan 14, 2026
Closed 6.95 (-2.0%) on Jan 14, 2026
Cereno Scientific to Attend JPM Week and Biotech Showcase in San Francisco, US, on January 12-18, 2026
Dec 12, 2025
Closed 7.50 (-1.0%) on Dec 12, 2025
Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
Dec 8, 2025
Closed 7.99 (-4.2%) on Dec 9, 2025
Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA
Nov 10, 2025
Closed 7.29 (-0.5%) on Nov 10, 2025
Decks
Nordic Health Summit Japan 2026
Conference · 9 slides · Apr 24, 2026
Technical Presentation (December 2025)
Technical · 14 slides · Dec 17, 2025
Technical Presentation (September 2024)
Technical · 57 slides · Sep 30, 2024
Investor Presentation (September 2022)
Investor deck · 21 slides · September 2022
Cereno Scientific AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 7 in all · newest Mar 31, 2026 · oldest 2025
- Decks
- 5 decks · latest Apr 24, 2026
Where Cereno Scientific AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:CRNOB · Home listing | Stockholm | Sweden | SEK |
| OTC:CRNOF · This page | OTC | United States | USD |
| LS Exchange:A2AM00 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AM00 | Lang & Schwarz | Germany | EUR |
| Frankfurt:4A1 | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Cereno Scientific AB.